MedTrace Logo

Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia

NCT04197180 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-11-07

No results posted yet for this study

Summary

This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia.

Conditions

  • Gastric Low Grade Intraepithelial Neoplasia

Interventions

PROCEDURE

Hybrid Argon Plasma Coagulation

Argon Plasma Coagulation after water injection for local ablation

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • Shenzhen Hospital of Southern Medical University

    collaborator OTHER

  • The Fifth Affiliated Hospital of Zunyi Medical College

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Philip WY Chiu, MD · Chinese University of Hong Kong

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04197180 on ClinicalTrials.gov